1. Home
  2. MITT vs TNXP Comparison

MITT vs TNXP Comparison

Compare MITT & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AG Mortgage Investment Trust Inc.

MITT

AG Mortgage Investment Trust Inc.

N/A

Current Price

$6.05

Market Cap

245.5M

Sector

Real Estate

ML Signal

N/A

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$9.90

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MITT
TNXP
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.5M
199.7M
IPO Year
2011
2008

Fundamental Metrics

Financial Performance
Metric
MITT
TNXP
Price
$6.05
$9.90
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $9.25
N/A
AVG Volume (30 Days)
297.4K
★ 411.2K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
★ 11.96%
N/A
EPS Growth
N/A
★ 91.75
EPS
★ 0.01
N/A
Revenue
N/A
★ $13,107,000.00
Revenue This Year
$3.48
$558.11
Revenue Next Year
$5.06
$38.29
P/E Ratio
$611.00
★ N/A
Revenue Growth
N/A
★ 29.85
52 Week Low
$5.93
$9.40
52 Week High
$9.27
$24.64

Technical Indicators

Market Signals
Indicator
MITT
TNXP
Relative Strength Index (RSI) 28.71 27.93
Support Level $5.93 $9.40
Resistance Level $6.85 $12.99
Average True Range (ATR) 0.16 0.56
MACD -0.03 -0.27
Stochastic Oscillator 12.03 9.00

Price Performance

Historical Comparison
MITT
TNXP

About MITT AG Mortgage Investment Trust Inc.

TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. The company focuses on its investment activities on acquiring and securitizing newly-originated residential mortgage loans within the non-agency segment of the housing market.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: